Beta blocker - PDFSEARCH.IO - Document Search Engine

Beta blocker
Results: 281

#	Item
61	Table 8(b): Significant drug groups (incl Drs bag) by highest volume, year end: Jun 2008 to year end: Jun[removed]Section 85 Only Year ending Jun 2008 ATC Group Level 2 Volume Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-01-19 18:01:25 Medicine Anatomy Beta blocker Renin-angiotensin system Angiotensin Renin Antibacterial Calcium channel blocker Biology Endocrinology Peptide hormones
62	Table 10(b): Significant drug groups (incl Drs bag) by highest volume, year end: Jun 2006 to year end: Jun[removed]Year ending Jun 2006 ATC Group Level 2 Year ending Jun 2007 Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-01-19 18:01:25 Medicine Anatomy Beta blocker Angiotensin Renin-angiotensin system Renin Antibacterial Calcium channel blocker Endocrinology Biology Peptide hormones
63	Table 7(b): Significant drug groups (incl Drs bag) by highest volume, year end: Jun 2009 to year end: Jun[removed]Section 85 Only Year ending Jun 2009 ATC Group Level 2 Volume Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-01-19 18:01:25 Medicine Anatomy Beta blocker Renin-angiotensin system Angiotensin Renin Calcium channel blocker Antibacterial Biology Endocrinology Peptide hormones
64	Table 8(b): Significant drug groups (incl Drs bag) by highest volume, year end: Jun 2007 to year end: Jun[removed]Section 85 Only Year ending Jun 2007 ATC Group Level 2 Year ending Jun 2008 Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-01-19 18:01:25 Medicine Anatomy Beta blocker Renin-angiotensin system Angiotensin Renin Antibacterial Calcium channel blocker Endocrinology Biology Peptide hormones
65	Table 7(b): Significant drug groups (incl Drs bag) by highest volume, year end: Jun 2013 to year end: Jun[removed]Section 85 Only Year ending Jun 2013 ATC Group Level 2 Volume Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-01-27 18:14:28 Anatomy Beta blocker Renin-angiotensin system Angiotensin Antibacterial Calcium channel blocker Endocrinology Medicine Biology
66	Table 7(b): Significant drug groups (incl Drs bag) by highest volume, year end: Jun 2010 to year end: Jun[removed]Section 85 Only Year ending Jun 2010 ATC Group Level 2 Volume Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-01-19 18:01:25 Anatomy Beta blocker Renin-angiotensin system Angiotensin Antibacterial Calcium channel blocker Endocrinology Medicine Biology
67	Table 7(b): Significant drug groups (incl Drs bag) by highest volume, year end: Jun 2012 to year end: Jun[removed]Section 85 Only Year ending Jun 2012 ATC Group Level 2 Volume Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2015-01-19 18:01:26 Anatomy Beta blocker Renin-angiotensin system Angiotensin Antibacterial Calcium channel blocker Endocrinology Medicine Biology
68	Module 7 Drug Treatment for People with Hypertension Treatment algorithm Drug treatment for essential HT Add to Reading List Source URL: www.pco.gov.hk Language: English - Date: 2013-04-18 00:52:03 Health ACE inhibitors Antihypertensive drug Organochlorides Thiazide Beta blocker Angiotensin II receptor antagonist Perindopril Complications of hypertension Hypertension Medicine Chemistry
69	Module 7 Drug Treatment in Type 2 Diabetes with Hypertension  Hypertension is 1.5 – 2 times more prevalent in Type 2 diabetes (prevalence Add to Reading List Source URL: www.pco.gov.hk Language: English - Date: 2013-04-03 07:04:00 Hypertension Alcohols ACE inhibitors Amides Antihypertensive drug Kidney diseases Losartan Beta blocker Diabetic nephropathy Medicine Health Chemistry
70	Module 7 Drug Treatment for People with Hypertension Treatment algorithm Drug treatment for essential HT Add to Reading List Source URL: www.pco.gov.hk Language: English - Date: 2013-04-18 00:52:03 Health ACE inhibitors Antihypertensive drug Organochlorides Thiazide Beta blocker Angiotensin II receptor antagonist Perindopril Complications of hypertension Hypertension Medicine Chemistry

UPDATE